GO
Loading...

GSK 'getting off to a slow start': Pro

Wednesday, 23 Jul 2014 | 8:42 PM ET

Raghuram Selvaraju, Head of Healthcare Equity Research at Aegis Capital, outlines the factors that weighed on GlaxoSmithKline's second quarter earnings.